Tower Research Capital (TRC)’s Ensysce Biosciences ENSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.05K | Buy |
1,369
+928
| +210% | +$2.07K | ﹤0.01% | 4559 |
|
|
2025
Q1 | $1.13K | Buy |
441
+3
| +0.7% | +$8 | ﹤0.01% | 4770 |
|
|
2024
Q4 | $3.57K | Buy |
438
+8
| +2% | +$65 | ﹤0.01% | 4638 |
|
|
2024
Q3 | $1.55K | Sell |
430
-120
| -22% | -$432 | ﹤0.01% | 5138 |
|
|
2024
Q2 | $4.19K | Buy |
550
+6
| +1% | +$46 | ﹤0.01% | 4808 |
|
|
2024
Q1 | $6.45K | Buy |
544
+124
| +30% | +$1.47K | ﹤0.01% | 4367 |
|
|
2023
Q4 | $6.69K | Buy |
420
+158
| +60% | +$2.52K | ﹤0.01% | 4710 |
|
|
2023
Q3 | $5.42K | Buy |
262
+2
| +0.8% | +$41 | ﹤0.01% | 4721 |
|
|
2023
Q2 | $7.02K | Buy |
260
+216
| +491% | +$5.83K | ﹤0.01% | 4608 |
|
|
2023
Q1 | $3K | Buy |
44
+40
| +1,000% | +$2.73K | ﹤0.01% | 5185 |
|
|
2022
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 5580 |
|
|
2022
Q3 | $3K | Buy |
4
+3
| +300% | +$2.25K | ﹤0.01% | 5383 |
|
|
2022
Q2 | $3K | Sell |
1
-2
| -67% | -$6K | ﹤0.01% | 5367 |
|
|
2022
Q1 | $12K | Sell |
3
-6
| -67% | -$24K | ﹤0.01% | 4053 |
|
|
2021
Q4 | $153K | Buy |
9
+6
| +200% | +$102K | ﹤0.01% | 1959 |
|
|
2021
Q3 | $32K | Buy |
+3
| New | +$32K | ﹤0.01% | 3305 |
|